Skip to main content
Clinical Trials/ACTRN12616001184460
ACTRN12616001184460
Completed
未知

Evaluating transcatheter arterial embolisation for improvement of pain in OA of the knee – a randomised controlled trial

Barwon Medical Imaging0 sites59 target enrollmentAugust 29, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Barwon Medical Imaging
Enrollment
59
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 29, 2016
End Date
August 31, 2021
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Barwon Medical Imaging

Eligibility Criteria

Inclusion Criteria

  • 1\. People aged 18 to 75 years
  • 2\. Grade 2 knee OA (obtained via baseline imaging (X\-Ray) as per Kellgren\-Lawrence Grading Scale)
  • 3\. Moderate to severe knee pain
  • 4\. Knee pain for at least six months
  • 5\. Pain resistant to conservative treatment
  • a. Conservative treatment includes medication (e.g. paracetamol, anti\-inflammatories), or intra\-articular injections, or physiotherapy or exercise, or weight loss.
  • 6\. Participants must be willing, able and mentally competent to provide informed consent (able to read and understand the Patient Information and Consent Form)

Exclusion Criteria

  • 1\. Local infection
  • 2\. Active malignancy
  • 3\. Rheumatoid Arthritis or Seronegative Arthropathies
  • 4\. Prior Ipsilateral Knee Surgery
  • 5\. Kellgren\-Lawrence Grade 3 and above
  • 6\. Current pregnancy
  • a. If participant is unsure of their current pregnancy status clarification from their GP including arranging a pregnancy test and following up the result can be obtained
  • 7\. Known history of allergy to contrast media
  • 8\. Weight greater than 200kg
  • 9\. Barwon Medical Imaging Protocols:

Outcomes

Primary Outcomes

Not specified

Similar Trials